Your browser doesn't support javascript.
loading
The evolution of resistance and tolerance as cancer defences.
Thomas, Frédéric; Giraudeau, Mathieu; Gouzerh, Flora; Boutry, Justine; Renaud, François; Pujol, Pascal; Tasiemski, Aurélie; Bernex, Florence; Maraver, Antonio; Bousquet, Emilie; Dormont, Laurent; Osterkamp, Jens; Roche, Benjamin; Hamede, Rodrigo; Ujvari, Beata.
Afiliação
  • Thomas F; CREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.
  • Giraudeau M; CREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.
  • Gouzerh F; CREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.
  • Boutry J; CREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.
  • Renaud F; CREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.
  • Pujol P; CREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.
  • Tasiemski A; Service de Génétique Médicale et Chromosomique. Unité d'Oncogénétique, CHRU de Montpellier, Hôpital Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295Montpellier, France.
  • Bernex F; SPICI, Université de Lille, France.
  • Maraver A; IRCM/RHEM, ICM, BioCampus Montpellier, CNRS, INSERM, Univ Montpellier, Montpellier, France.
  • Bousquet E; IRCM/RHEM, ICM, BioCampus Montpellier, CNRS, INSERM, Univ Montpellier, Montpellier, France.
  • Dormont L; IRCM/RHEM, ICM, BioCampus Montpellier, CNRS, INSERM, Univ Montpellier, Montpellier, France.
  • Osterkamp J; Centre d'Ecologie Fonctionnelle et Evolutive, CNRS UMR 5175, Montpellier Cedex 5, France.
  • Roche B; Department of Surgery and Transplantation, Rigshospitalet, Blegdamsvej, DK -2100Copenhagen Ø, Denmark.
  • Hamede R; CREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.
  • Ujvari B; IRD, Sorbonne Université, UMMISCO, F-93143, Bondy, France.
Parasitology ; 147(3): 255-262, 2020 03.
Article em En | MEDLINE | ID: mdl-31727197
ABSTRACT
Although there is a plethora of cancer associated-factors that can ultimately culminate in death (cachexia, organ impairment, metastases, opportunistic infections, etc.), the focal element of every terminal malignancy is the failure of our natural defences to control unlimited cell proliferation. The reasons why our defences apparently lack efficiency is a complex question, potentially indicating that, under Darwinian terms, solutions other than preventing cancer progression are also important contributors. In analogy with host-parasite systems, we propose to call this latter option 'tolerance' to cancer. Here, we argue that the ubiquity of oncogenic processes among metazoans is at least partially attributable to both the limitations of resistance mechanisms and to the evolution of tolerance to cancer. Deciphering the ecological contexts of alternative responses to the cancer burden is not a semantic question, but rather a focal point in understanding the evolutionary ecology of host-tumour relationships, the evolution of our defences, as well as why and when certain cancers are likely to be detrimental for survival.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Evolução Biológica / Interações Hospedeiro-Parasita / Tolerância Imunológica / Antibiose / Neoplasias Limite: Animals Idioma: En Revista: Parasitology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Evolução Biológica / Interações Hospedeiro-Parasita / Tolerância Imunológica / Antibiose / Neoplasias Limite: Animals Idioma: En Revista: Parasitology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França